Other languages Agilent Technologies, Inc.

Equities

A

US00846U1016

Market Closed - Nyse Other stock markets 21:00:01 29/04/2024 BST			5-day change	1st Jan Change
139.6 ^USD	+1.34%		+0.28%	+0.40%

04-29	Agilent Technologies, Inc. Appoints Simon May as President of the Diagnostics and Genomics Group, Effective May 6, 2024	CI
04-22	Bernstein Adjusts Agilent Technologies' Price Target to $130 From $127	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Agilent Technologies, Inc. Appoints Simon May as President of the Diagnostics and Genomics Group, Effective May 6, 2024	04-29
Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed	04-09
Transcenta Partners with Agilent to Develop Claudin18.2 Companion Diagnostic	04-09
Transcenta Holding Limited Announces Collaboration with Agilent Technologies to Develop a Claudin18.2 Companion Diagnostic to Support TranStar301 Global Phase III Trial	04-08
RECOMENDACIONES DE LOS ANALISTAS EE.UU./UK : Agilent Technologies, Eaton Corporation, Citigroup, Royal Bank of Canada, Newmont Corporation....	04-05
Agilent Technologies, Inc. At AACR 2024: Empowering Breakthroughs in Cancer Research and Diagnostics	04-03
Agilent Technologies Inc. and University of California San Diego Launch Center of Excellence in Cellular Intelligence	04-02
Agilent Technologies Inc. Launches New Advanced Dilution System to Increase Lab Efficiency	04-01
Agilent Technologies Insider Sold Shares Worth $417,096, According to a Recent SEC Filing	03-27
Masimo Activist Investor Politan Capital Nominates 2 Board Candidates	03-25
Masimo Activist Investor Politan Capital Nominates 2 Board Candidates	03-25
Activist investor Politan plans second proxy battle at Masimo, WSJ reports	03-24
Agilent Technologies Insider Sold Shares Worth $7,844,550, According to a Recent SEC Filing	03-12
Exclusive-Icahn drops Illumina board challenge threat, sources say	03-12
Agilent reports better-than-expected first quarter results, shares rise	02-27
Agilent Fiscal Q1 Tops Estimates; Q2 Guidance Issued	02-27
Agilent Technologies, Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2024	02-27
Agilent Technologies, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024	02-27
Wall Street koerst af op vlakke opening	02-27
Amerikaanse futures wijzen op licht hogere opening Wall Street	02-27

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Agilent Technologies, Inc.

Equities

A

US00846U1016

Other languages

Filters